StonvexLoading…
StonvexStonvexStonvexCore line items from EXEL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-03 | Annual 2026 2026-01-02 | Q4 2025 2025-10-03 | Q3 2025 2025-07-04 |
|---|---|---|---|---|
Revenue | $610.81M | $2.32B | $1.72B | $1.12B |
Operating Income | $251.34M | $872.19M | $636.98M | $400.44M |
Net Income | $210.47M | $782.57M | $538.04M | $344.46M |
EPS (Diluted) | $0.79 | $2.78 | $1.90 | $1.20 |
Total Assets | $2.59B | $2.84B | $2.82B | $2.68B |
Total Liabilities | $657.85M | $683.10M | $662.85M | $644.54M |
Cash & Equivalents | $226.15M | $482.49M | $376.30M | $164.43M |
Free Cash Flow OCF − CapEx | $250.34M | $875.84M | $543.48M | $254.64M |
Shares Outstanding | 253.70M | 262.48M | 268.10M | 270.13M |